Debbie's Dream Foundation

CURING STOMACH CANCER

Donate
VIEW EVENTS
OSU 6.15.2020 fLYER

We've partnered with OSUCCC-James Cancer Hospital and Solove Research Institute to bring you the latest information in stomach cancer research. Watch the recordings of our recent May 16, 2020, Symposium.

Click here to watch recordings

March 20, 2020 – Care of Individuals with Cancer During COVID-19

By Brittnay Starks | March 20, 2020

ASCO invited its members to submit questions about issues and challenges they see emerging while caring for individuals with cancer in the context of the coronavirus pandemic. Currently, limited clinical cancer-specific data are available and information is evolving. The following information is based on evidence gathered through a PubMed searches of the medical literature, a…

January 30, 2020 – Family History of Gastric Cancer and Helicobacter Pylori Treatment

By Jackie Bello | January 30, 2020

Helicobacter pylori infection and a family history of gastric cancer are the main risk factors for gastric cancer. Whether treatment to eradicate H. pylori can reduce the risk of gastric cancer in persons with a family history of gastric cancer in first-degree relatives is unknown. View Full Article

January 15, 2020 – Early-Onset Gastric Cancer, Distinct From Traditional Disease, On The Rise In US

By Brittnay Starks | January 16, 2020

Incidence of early-onset gastric cancer that is clinically and genetically distinct from late-onset disease has increased steadily in the United States, an “alarming phenomenon” that warrants further research, according to a study published in Surgery. “There is an increasing trend of young patients diagnosed with gastric cancer, but without any of the traditional risk factors…

January 6, 2020 – Leap, BeiGene to Develop Immunotherapy for Gastric Cancer

By Brittnay Starks | January 6, 2020

US based Leap Therapeutics, Inc. a biotechnology company developing targeted immuno-oncology therapeutics, and China headquartered BeiGene, Ltd., a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology drugs for the treatment of cancer, on 3 Jan 2020 announced an exclusive option and license agreement for the clinical development and commercialization of DKN-01,…

November 16, 2019 – FDA Approves Talicia To Treat Superbug Linked To Stomach Cancer

By Brittnay Starks | November 16, 2019

Health officials are increasingly concerned about the rise of antibiotic-resistant infections, also known as ‘superbugs’. However, this month an Israel-based pharmaceutical company showed that we may be able to combat this threat. View Full Article

November 12, 2019 – FDA Grants Breakthrough Status to AI-Based Gastric Cancer Diagnostic

By Brittnay Starks | November 12, 2019

The FDA granted breakthrough device designation to AI Medical Service’s technology for diagnosing gastric cancer, the company said Monday. The technology uses artificial intelligence to analyze endoscopy images for signs of gastric cancer, a hard-to-diagnose disease associated with a high rate of false negatives. AI Medical Service, which raised $42.9 million last month, is working to bring…

November 1, 2019 – Taiho Oncology Joins Efforts To Improve Awareness Of Gastric Cancer With Support Of Leading Advocacy Groups

By Brittnay Starks | November 1, 2019

Recognizing a need for greater awareness and education around gastric cancer, Taiho Oncology, Inc., today announced its support of four leading gastric cancer advocacy organizations in observance of National Gastric Cancer Awareness Month. The company is sponsoring patient and caregiver programs, education and research throughout 2019 on behalf of Debbie’s Dream Foundation, the Gastric Cancer…

October 14, 2019 – ANALYSIS OF PATIENTS WITH PRIOR GASTRECTOMY TREATED WITH LONSURF® (TRIFLURIDINE AND TIPIRACIL) PUBLISHED IN JAMA ONCOLOGY

By Brittnay Starks | October 14, 2019

Taiho Oncology, Inc. announced today that detailed results from the analysis of patients with prior gastrectomy enrolled in the Phase 3 TAS-102 Gastric Study (TAGS) evaluating LONSURF® (trifluridine and tipiracil) in adult patients with metastatic gastric or gastroesophageal junction adenocarcinoma previously treated with at least two prior lines of chemotherapy that included a fluoropyrimidine, a platinum, either a taxane…

July 3, 2019 – Gastric Cancer Rates Higher Among Patients Treated For H. Pylori

By Brittnay Starks | August 1, 2019

Patients who receive antibiotic treatment for Helicobacter pylori infection experience gastric cancer at rates higher than the general population and several risk factors can increase that risk even further, according to data presented at Digestive Disease Week. View Full Article

July 4, 2019 – Study Uncovers Origin of Cell Layer that Hides Stomach Cancer

By Brittnay Starks | August 1, 2019

A group of researchers from Hiroshima recently discovered the origin of a normal-looking stomach lining that covers sites of gastric cancer and makes it difficult to spot after the eradication of an H. pylori infection. H. pylori infection is a major cause of stomach cancer and causes inflammation by releasing substances that can destroy cells…

What are you searching for?

Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
Articles
Board of Directors
Corporate Advisory Council
Directors
Honorary Board
Scientific and Medical Advisory Board
Staff
Uncategorized

Raising Awareness. Funding Research. Supporting Patients. Achieving the DREAM!

Debbie's Dream Foundation: Curing Stomach Cancer (DDF) is dedicated to raising awareness about stomach cancer, advancing funding for research, and providing education and support internationally to patients, families, and caregivers. DDF seeks as its ultimate goal to make the cure for stomach cancer a reality.

Patient Resource Education Program
Stomach Cancer 101
Become an Advocate

Debbie's Dream Foundation's Response to COVID-19

Debbie’s Dream Foundation: Curing Stomach Cancer (DDF) cares about the general well-being of our community. With the unforeseeable spread of the coronavirus (COVID-19), we are doing our part in minimizing the spread of this disease by participating in “social distancing” as outlined in the Centers for Disease Control and Prevention guidelines. As a result, we have decided to cancel some of our upcoming events, and our staff is currently working remotely to comply with the latest recommendations of the CDC and other government and healthcare organizations.

 

Read more

News & Updates

 

March 20, 2020 – Care of Individuals with Cancer During COVID-19

ASCO invited its members to submit questions about issues and challenges they see emerging while caring for individuals with cancer…

Read More

Survivor Stories

Denise Leprine-New York

It all began in Oct 2016 when I was going for routine blood work every few months after being diagnosed…

Read More

Keep up with the latest news and events:

September

2020

Upcoming Events

Monthly Stomach Cancer Support Groups 

September 4, 2020

Debbie’s Dream Foundation: Curing Stomach Cancer is proud to partner with Catholic Hospice, Inc. to bring patients and caregivers monthly support groups via teleconference. The patient group will begin at 1:30 p.m. EST and the caregiver group will begin at 2:30 p.m. EST, each at an hour long.

2020 Clinical Trial Updates

September 11, 2020

Join Debbie’s Dream Foundation and Dr. James Cleary for a presentation on the latest updates in clinical trials. The presentation will also include a live Q & A session with the doctor following the presentation.

HOW YOU CAN HELP DDF

DONATE

ADVOCATE

SHOP DDF

VOLUNTEER